I would like to thank Viva Rasé for not only being our mentor, but also our advisor. I would also like to thank Xcel Energy for sponsoring our research as well as our parents for sponsoring our room and board. I would also like to thank University of Northern Colorado and the MAST Institute along with Lori Ball for making Frontiers of Science Institute possible.
References
[1] Breast Cancer: Statistics. (2018, May 23). Retrieved from https://www.cancer.net/cancer-types/breast-cancer/statistics
[2] Fujimura, T., Kambayashi, Y., & Aiba, S. (2012, November 01). Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518528/
[3] Gabrilovich, D. I., & Nagaraj, S. (2009, March). Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828349/
[4] Disis, M. L. (2010, October 10). Immune Regulation of Cancer. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3041789/
[5] Immune evasion in cancer: Mechanistic basis and therapeutic strategies. (2015, March 24). Retrieved from https://www.sciencedirect.com/science/article/pii/S1044579X1500019X
[6] Nicholson, L. (2016, October 31). Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5091071/
[7] Niedbala, W., Cai, B., & Liew, F. Y. (2006, November). Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1798386/
[8] Bronte, V., & Gabrilovich, D. (2010). Myeloid-derived suppressor cells [Poster]. Padova, Italy: Macmillan.
[9] Mundy, G. R., Yoneda, T., & Hiraga, T. (2005, October 01). Preclinical studies with zoledronic acid and other bisphosphonates: Impact on the bone microenvironment. Retrieved from https://www.sciencedirect.com/science/article/pii/S0093775401902635
[10] Youn, J., & Gabrilovich, D. I. (2010, November). Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3277452/
[11] Talmadge, J. E., PhD, & Gabrilovich, D. I., PhD. (n.d.). History of myeloid derived suppressor cells (MDSCs) in the macro- and micro-environment of tumour-bearing hosts. History of Myeloid Derived Suppressor Cells (MDSCs) in the Macro- and Micro-environment of Tumour-bearing Hosts. doi:10.3897/bdj.4.e7720.figure2f
[12] Ibáñez-Vea, M., Zuazo, M., Gato, M., Arasanz, H., Fernández-Hinojal, G., Escors, D., & Kochan, G. (2017). Myeloid-Derived Suppressor Cells in the Tumor Microenvironment: Current Knowledge and Future Perspectives. Archivum Immunologiae Et Therapiae Experimentalis,66(2), 113-123. doi:10.1007/s00005-017-0492-4
[13] Connector Accessories, Electrical, Backshell, Nonenvironmental, 45°, Shield Termination, Category 3A (For MIL-C-5015 Crimp, MIL-C-26482 Series 2, MIL-C-81703 Series 3, and MIL-C-83723 Series III. (n.d.). doi:10.4271/as85049/23
[14] Figure 2f from: Irimia R, Gottschling M (2016) Taxonomic revision of Rochefortia Sw. (Ehretiaceae, Boraginales). Biodiversity Data Journal 4: E7720. https://doi.org/10.3897/BDJ.4.e7720. (n.d.). doi:10.3897/bdj.4.e7720.figure2f
[15] Figure 2f from: Irimia R, Gottschling M (2016) Taxonomic revision of Rochefortia Sw. (Ehretiaceae, Boraginales). Biodiversity Data Journal 4: E7720. https://doi.org/10.3897/BDJ.4.e7720. (n.d.). doi:10.3897/bdj.4.e7720.figure2f
[16] Luker, G. D. (2004). Imaging CXCL12-CXCR4 Regulation of Breast Cancer Metastases. Research Gate. doi:10.21236/ada433943
[17] The good and bad faces of the CXCR4 chemokine receptor. (2017, December 27). Retrieved from https://www.sciencedirect.com/science/article/pii/S135727251730331X?via=ihub
[18] T Cells. (n.d.). Retrieved from https://www.nationalmssociety.org/What-is-MS/Definition-of-MS/T-cells
[19] Umansky, V., Blattner, C., Gebhardt, C., & Utikal, J. (2016, December). Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192356/
[20] Overview of Western Blotting | Thermo Fisher Scientific - US. (n.d.). Retrieved from https://www.thermofisher.com/us/en/home/life-science/protein-biology/protein-biology-learning-center/protein-biology-resource-library/pierce-protein-methods/overview-western-blotting.html
[21] DNA Phosphorylation. (n.d.). Retrieved from https://content.neb.com/applications/dna-modification/dna-end-modification/dna-phosphOrylation
[22] Zhang Lab CRISPR Plasmids Available from Addgene. (n.d.). Retrieved from https://www.addgene.org/crispr/zhang/
[23] Lipofectamine 3000 Transfection Reagent. (n.d.). Retrieved from https://www.thermofisher.com/order/catalog/product/L3000150
[2] Fujimura, T., Kambayashi, Y., & Aiba, S. (2012, November 01). Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518528/
[3] Gabrilovich, D. I., & Nagaraj, S. (2009, March). Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828349/
[4] Disis, M. L. (2010, October 10). Immune Regulation of Cancer. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3041789/
[5] Immune evasion in cancer: Mechanistic basis and therapeutic strategies. (2015, March 24). Retrieved from https://www.sciencedirect.com/science/article/pii/S1044579X1500019X
[6] Nicholson, L. (2016, October 31). Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5091071/
[7] Niedbala, W., Cai, B., & Liew, F. Y. (2006, November). Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1798386/
[8] Bronte, V., & Gabrilovich, D. (2010). Myeloid-derived suppressor cells [Poster]. Padova, Italy: Macmillan.
[9] Mundy, G. R., Yoneda, T., & Hiraga, T. (2005, October 01). Preclinical studies with zoledronic acid and other bisphosphonates: Impact on the bone microenvironment. Retrieved from https://www.sciencedirect.com/science/article/pii/S0093775401902635
[10] Youn, J., & Gabrilovich, D. I. (2010, November). Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3277452/
[11] Talmadge, J. E., PhD, & Gabrilovich, D. I., PhD. (n.d.). History of myeloid derived suppressor cells (MDSCs) in the macro- and micro-environment of tumour-bearing hosts. History of Myeloid Derived Suppressor Cells (MDSCs) in the Macro- and Micro-environment of Tumour-bearing Hosts. doi:10.3897/bdj.4.e7720.figure2f
[12] Ibáñez-Vea, M., Zuazo, M., Gato, M., Arasanz, H., Fernández-Hinojal, G., Escors, D., & Kochan, G. (2017). Myeloid-Derived Suppressor Cells in the Tumor Microenvironment: Current Knowledge and Future Perspectives. Archivum Immunologiae Et Therapiae Experimentalis,66(2), 113-123. doi:10.1007/s00005-017-0492-4
[13] Connector Accessories, Electrical, Backshell, Nonenvironmental, 45°, Shield Termination, Category 3A (For MIL-C-5015 Crimp, MIL-C-26482 Series 2, MIL-C-81703 Series 3, and MIL-C-83723 Series III. (n.d.). doi:10.4271/as85049/23
[14] Figure 2f from: Irimia R, Gottschling M (2016) Taxonomic revision of Rochefortia Sw. (Ehretiaceae, Boraginales). Biodiversity Data Journal 4: E7720. https://doi.org/10.3897/BDJ.4.e7720. (n.d.). doi:10.3897/bdj.4.e7720.figure2f
[15] Figure 2f from: Irimia R, Gottschling M (2016) Taxonomic revision of Rochefortia Sw. (Ehretiaceae, Boraginales). Biodiversity Data Journal 4: E7720. https://doi.org/10.3897/BDJ.4.e7720. (n.d.). doi:10.3897/bdj.4.e7720.figure2f
[16] Luker, G. D. (2004). Imaging CXCL12-CXCR4 Regulation of Breast Cancer Metastases. Research Gate. doi:10.21236/ada433943
[17] The good and bad faces of the CXCR4 chemokine receptor. (2017, December 27). Retrieved from https://www.sciencedirect.com/science/article/pii/S135727251730331X?via=ihub
[18] T Cells. (n.d.). Retrieved from https://www.nationalmssociety.org/What-is-MS/Definition-of-MS/T-cells
[19] Umansky, V., Blattner, C., Gebhardt, C., & Utikal, J. (2016, December). Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192356/
[20] Overview of Western Blotting | Thermo Fisher Scientific - US. (n.d.). Retrieved from https://www.thermofisher.com/us/en/home/life-science/protein-biology/protein-biology-learning-center/protein-biology-resource-library/pierce-protein-methods/overview-western-blotting.html
[21] DNA Phosphorylation. (n.d.). Retrieved from https://content.neb.com/applications/dna-modification/dna-end-modification/dna-phosphOrylation
[22] Zhang Lab CRISPR Plasmids Available from Addgene. (n.d.). Retrieved from https://www.addgene.org/crispr/zhang/
[23] Lipofectamine 3000 Transfection Reagent. (n.d.). Retrieved from https://www.thermofisher.com/order/catalog/product/L3000150